Early Allograft Dysfunction
7
1
1
2
Key Insights
Highlights
Success Rate
67% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 47/100
14.3%
1 terminated out of 7 trials
66.7%
-19.9% vs benchmark
0%
0 trials in Phase 3/4
150%
3 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (7)
Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation
Intraoperative Assessment of Microcirculatory Function Using Vascular Occlusion Test During Liver Transplantation
New Biomarkers for Organ Viability Assessment During Hypothermic Machine Perfusion in Liver Transplantation: the Role of Extemporaneous Histological Examination.
Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation
HOPE With Cytokine Filtration in Liver Transplantation (Cyto-HOPE)
Controlled Attenuation Parameter (CAP) in Liver Allografts
Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus